✦ LIBER ✦

Conversion of phase modulation to amplitude modulation using a phase conjugate mirror

✍ Scribed by Michel Piché; Claude Paré; Pierre-André Bélanger

Publisher: Elsevier Science
Year: 1988
Tongue: English
Weight: 344 KB
Volume: 65
Category: Article
ISSN: 0030-4018
DOI: 10.1016/0030-4018(88)90287-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Investigation of grating dynamics using

Investigation of grating dynamics using a phase conjugate mirror

✍ T. Shimura; S.A. Boothroyd; J. Chrostowski; P. Myslinski 📂 Article 📅 1993 🏛 Elsevier Science 🌐 English ⚖ 853 KB

Evanescent coupling of a dipole to a pha

Evanescent coupling of a dipole to a phase conjugate mirror

✍ Girish S. Agarwal; S. Dutta Gupta 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 634 KB

Generation of Phase-Modulated Adiabatic

Generation of Phase-Modulated Adiabatic RF Pulses on Spectrometers Equipped with a Single, Amplitude RF Modulator

✍ H. Lahrech; J.L. Leviel; C. Delonmartin; H. Reutenauer; M. Decorps 📂 Article 📅 1995 🏛 Elsevier Science 🌐 English ⚖ 208 KB

Solid-Phase Chemistry: A Useful Tool to

Solid-Phase Chemistry: A Useful Tool to Discover Modulators of Protein Interactions

✍ Mar Orzaez; Puig Mora; Laura Mondragon; Enrique Perez-Paya; Maria J. Vicent 📂 Article 📅 2007 🏛 John Wiley and Sons ⚖ 11 KB

Dynamical behavior of a single-mode lase

Dynamical behavior of a single-mode laser coupled to a phase-conjugate mirror

✍ B.H.W. Hendriks; M.A.M. de Jong; G. Nienhuis 📂 Article 📅 1990 🏛 Elsevier Science 🌐 English ⚖ 640 KB

Dual modulation of 5-fluorouracil using

Dual modulation of 5-fluorouracil using leucovorin and hydroxyurea. A phase I trial

✍ J. Lokich; N. Anderson; M. Bern; F. Coco; T. Zipoli; C. Moore; L. Gonsalves 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 318 KB 👁 2 views

Oral hydroxyurea (HU) was added to a regimen of 5-fluorouracil(5-FU) plus leucovorin (LCV) administered as a continuous 24-hour infusion for 14 days. A previous report of the 5-FU plus LCV infusion established optimal dosages of 200 mg/mz/d and 5 mg/mz/d, respectively, for each agent. Oral HU was ad